Literature DB >> 3207976

Responses to 5-hydroxytryptamine evoked in the hemisected spinal cord of the neonate rat.

L A Connell1, D I Wallis.   

Abstract

1. Superfusion of isolated hemisected spinal cord from neonate rats with 5-hydroxytryptamine (5-HT) (10(-6) to 10(-3) M) evoked concentration-related depolarizations. The maximal depolarization elicited by a concentration of 10(-4) M was 1.0 +/- 0.1 mV (mean +/- s.e.mean, n = 30). Noradrenaline in a similar range of concentrations also elicited depolarizations. 2. The depolarizations probably originate in motoneurones as a result of direct interaction of the amines with these cells, since responses were unaltered by tetrodotoxin (10(-7) M) or Ca2+-free/Mg2+-rich medium. 3. 5-Carboxamidotryptamine (5-CT), S(+)-alpha-methyl-5-hydroxytryptamine (alpha-Me5-HT) and 5-methoxytryptamine (5-MeOT) evoked similar depolarizations to 5-HT. Tryptamine evoked depolarizations of smaller maximal amplitude. 5-Hydroxytryptophan, 2-methyl-5-hydroxytryptamine, 8-hydroxy-2-(di-N-propylamino) tetralin hydrobromide (8-OH-DPAT) and 5-methoxy-3-[1,2,3,6-tetrahydro-4-pyridinyl]-1-H-indole succinate (RU 24969) had no depolarizing action. 4. Concentration-response (CR) curves were determined for 5-HT, 5-CT, alpha-Me5-HT, 5-MeOT and tryptamine. The ED50 value for 5-HT was 20.5 +/- 1.2 microM. The equipotent molar ratios (EPMRs) for 5-CT and alpha-Me5-HT were close to unity, while 5-MeOT was approximately 3 times and tryptamine 13 to 14 times less potent than 5-HT. 5. The relative agonist potency of 5-HT with respect to other tryptamine analogues capable of depolarizing motoneurones was increased when 5-HT uptake was blocked by citalopram (10(-7) M). In the presence of citalopram, 5-HT was 2.7 times more potent than alpha-Me5-HT and 16.9 times more potent than 5-CT. The apparent order of potency was 5-HT greater than alpha-Me5-HT greater than 5-CT (greater than 5-MeOT much greater than tryptamine). 6. The monoamine oxidase inhibitor, pargyline (5 x 10(-4) M), had no effect on depolarizations to 5-HT, 5-CT or alpha-Me5-HT. 7. Methiothepin, 1 alpha H, 3 alpha, 5H-tropan-3-yl-3,5-dichlorobenzoate methanesulphonate (MDL 72222) and [3 alpha-tropanyl]-1H-indole-3-carboxylic acid ester hydrochloride (ICS 205-930) had no effect on 5-HT depolarizations elicited in motoneurones. Ketanserin (0.75 x 10(-7) M to 10(-6) M) showed modest antagonistic action and depressed maximal response amplitude; the pIC50 was 6.5. 8. Methysergide (10-8 to 10- 7M) was a potent antagonist of responses to 5-HT. CR curves were displaced to the right and flattened in the presence of the antagonist. The pIC5o assessed from the effect on depolarizations evoked by 5-HT 1O-4M was 7.5. 9. It is concluded that 5-HT acts directly to depolarize mammalian spinal motoneurones through receptors that are also activated by 5-CT, alpha-MeS-HT and 5-MeOT and are blocked by methysergide. The receptor profile, although not 5-HT3-like, does not clearly coincide with that for either 5-HT1-like or 5-HT2 receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207976      PMCID: PMC1854111          DOI: 10.1111/j.1476-5381.1988.tb11628.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Ionic dependency of ventral root responses to excitatory amino acids in isolated spinal cord of frog and rat [proceedings].

Authors:  R H Evans; A A Francis; J C Watkins
Journal:  J Physiol       Date:  1976-12       Impact factor: 5.182

2.  Electrophysiology of mammalian spinal cord in vitro.

Authors:  M Otsuka; S Konishi
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

3.  Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine.

Authors:  P B Bradley; I Briggs
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

4.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

5.  Pharmacological characterization of serotonin receptors in the facial motor nucleus: a microiontophoretic study.

Authors:  R B McCall; G K Aghajanian
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

6.  Facilitation of spinal motoneurone excitability by 5-hydroxytryptamine and noradrenaline.

Authors:  S R White; R S Neuman
Journal:  Brain Res       Date:  1980-04-21       Impact factor: 3.252

7.  Serotonergic facilitation of facial motoneuron excitation.

Authors:  R B McCall; G K Aghajanian
Journal:  Brain Res       Date:  1979-06-15       Impact factor: 3.252

8.  The mode of action of 5-hydroxytryptophan in facilitating a stretch reflex in the spinal cat.

Authors:  P H Ellaway; J R Trott
Journal:  Exp Brain Res       Date:  1975       Impact factor: 1.972

9.  Intracellular studies showing modulation of facial motoneurone excitability by serotonin.

Authors:  C P VanderMaelen; G K Aghajanian
Journal:  Nature       Date:  1980-09-25       Impact factor: 49.962

10.  Characteristics of dorsal root potentials recorded from the isolated spinal cord of the neonate rat.

Authors:  P R Preston; D I Wallis
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

View more
  12 in total

1.  Analysis of the 5-HT receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria for receptor classification.

Authors:  G R Martin; S J MacLennan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Proceedings of the British Pharmacological Society Meeting. Sheffield, 18-20th April 1990.

Authors: 
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

Review 3.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

4.  5-Hydroxytryptamine responses in neonate rat motoneurones in vitro.

Authors:  M Y Wang; N J Dun
Journal:  J Physiol       Date:  1990-11       Impact factor: 5.182

5.  Voltage-dependent block of NMDA responses by 5-HT agonists in ventral spinal cord neurones.

Authors:  D Chesnoy-Marchais; J Y Barthe
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

6.  The influence of 5-hydroxytryptamine agonists and antagonists on identified sympathetic preganglionic neurones in the rat, in vivo.

Authors:  D I Lewis; J H Coote
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

7.  Monoamines increase the excitability of spinal neurones in the neonatal rat by hyperpolarizing the threshold for action potential production.

Authors:  Brent Fedirchuk; Yue Dai
Journal:  J Physiol       Date:  2004-04-16       Impact factor: 5.182

8.  Further studies on the action of 5-hydroxytryptamine on lumbar motoneurones in the rat isolated spinal cord.

Authors:  D I Wallis; L A Connell; Z Kvaltinova
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-04       Impact factor: 3.000

9.  The excitability of lumbar motoneurones in the neonatal rat is increased by a hyperpolarization of their voltage threshold for activation by descending serotonergic fibres.

Authors:  Jonathan Gilmore; Brent Fedirchuk
Journal:  J Physiol       Date:  2004-04-30       Impact factor: 5.182

10.  Activation of the central pattern generators for locomotion by serotonin and excitatory amino acids in neonatal rat.

Authors:  J R Cazalets; Y Sqalli-Houssaini; F Clarac
Journal:  J Physiol       Date:  1992-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.